Nomination Committee for Biovica International AB for the 2024 Annual General Meeting

2024-04-11 08:00

The Nomination Committee prior to the 2024 Annual General Meeting will consist of three members, who shall represent the two shareholders with the highest number of shares who accept the assignment to be part of the Nomination Committee as of December 31, 2023, and the Chairman of the Board. The Nomination Committee then appoints a chairman among its members.

In accordance with the above guidelines, the Nomination Committee for the 2024 Annual General Meeting will consist of the following persons:

  • Anna Rylander Eklund, representing the Rylander family and associated companies.
  • Mats Danielsson, representing himself and Innovicum AB.
  • Lars Holmqvist, Chairman of the Board

The members of the Nomination Committee together represent approximately 17 percent of the shares and 25 percent of the votes in the company as of December 31, 2023.

The Nomination Committee's overall responsibility is to submit proposals regarding the Chairman at the Annual General Meeting, election and remuneration of Board members, election and remuneration of the auditor, as well as principles for the appointment of the Nomination Committee and instructions for the Nomination Committee.

Shareholders who wish to submit proposals to the company's nomination committee can do so via e-mail to or by letter to the address: Biovica International AB, Att: The Nomination Committee, Dag Hammarskjölds väg 54B, 752 37 Uppsala.


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program